Alphatec Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Alphatec Holdings, Inc. on December 29, 2014, reporting an event that occurred on December 22, 2014. The filing addresses Item 3.02 regarding unregistered sales of equity securities.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity issuance event.
Material Changes
On December 22, 2014, the Company issued 267,672 shares of common stock (par value $0.0001 per share), referred to as "Collaborator Shares." These shares were issued pursuant to a Collaboration Agreement dated October 22, 2013, between Alphatec Spine, Inc. (a wholly owned subsidiary) and the Collaborator (Elite Medical Holdings, LLC and Pac 3 Surgical Products, LLC). The issuance served as payment for consultation services related to product development activities during the first year of the agreement. The shares were distributed to 24 individuals and entities designated by the Collaborator.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the specific transaction details. The issuance relied on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933 for transactions not involving a public offering.
Key Facts for Investor Verification
- 267,672 shares of common stock were issued on December 22, 2014.
- The issuance was compensation for consultation services under a 2013 Collaboration Agreement.
- Shares were distributed to 24 designated recipients.
- The transaction was executed under a Section 4(a)(2) exemption from registration.
- No financial performance data is included in this specific filing.